Akari Therapeutics Plc
AKTX
Jodie situation report
Akari Therapeutics Plc's move is spreading beyond its market group.
No new filing conclusion is available. 12 of 21 group members are active now; 1 filing-linked outsider is moving with the group, and 0 of 1 directly disclosed connection is confirming.
- At least 14 of 21 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- IMMX remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 7 of 21 members or fewer.
Who this business touches
The relationships behind AKTX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
WXILYFiling-linked namepartnerMar 30, 2026 ▾
“The partnership with WuXi for these activities enables us to maintain an efficient, high quality, and reliable model to develop and supply our clinical material for future studies.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
AKTX is currently a Participant in the organic co-movement group Healthcare Innovators. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.